Skip to content

Clinical trials

Recruiting Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Status: Recruiting Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20221
20232
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Eli Lilly and Company1
Essen Biotech1
Nanfang Hospital, Southern Medical University1
Stanford University1
Turning Point Therapeutics, Inc.1
University Hospital, Angers1
VA Office of Research and Development1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic9
Lung Neoplasms8
Neoplasms8
Bronchial Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Lung Diseases6
Neoplasms by Site6
Respiratory Tract Diseases6
Respiratory Tract Neoplasms6
Thoracic Neoplasms6

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.